The lantibiotic gallidermin acts bactericidal against Staphylococcus epidermidis and Staphylococcus aureus and antagonizes the bacteria-induced proinflammatory responses in dermal fibroblasts

Genome database mining for the discovery of novel lantibiotics

(2017) Stephanie K. Sandiford   Expert Opinion on Drug Discovery

Dual action of bacteriocin PLNC8 αβ through inhibition of Porphyromonas gingivalis infection and promotion of cell proliferation

(2017) Torbjörn Bengtsson et al.   Pathogens and Disease

Antibiotic resistance

(2017) Marianne Frieri et al.   Journal of Infection and Public Health

Reflecting on the final report of the O'Neill Review on Antimicrobial Resistance

(2016) Laura J V Piddock   LANCET INFECTIOUS DISEASES

Antibacterial drug discovery in the resistance era

(2016) Eric D. Brown et al.   NATURE

Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options

(2016) S.M. Purrello et al.   Journal of Global Antimicrobial Resistance

Interaction of blood components with cathelicidins and their modified versions

(2015) Kai Yu et al.   BIOMATERIALS

The use of erythrocyte fragility to assess xenobiotic cytotoxicity

(2015) Maria Pagano et al.   CELL BIOCHEMISTRY AND FUNCTION

Bacteriocins and their position in the next wave of conventional antibiotics

(2015) Veronica L. Cavera et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Update on the antibiotic resistance crisis

(2014) Gian Maria Rossolini et al.   CURRENT OPINION IN PHARMACOLOGY

Porphyromonas gingivalis downregulates the immune response of fibroblasts

(2013) Eleonor Palm et al.   BMC MICROBIOLOGY

Methicillin-Resistant Staphylococcus aureus: An Evolving Pathogen

(2013) M. E. Stryjewski et al.   CLINICAL INFECTIOUS DISEASES

Epidermin and gallidermin: Staphylococcal lantibiotics

(2013) Friedrich Götz et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Lantibiotics: Promising candidates for future applications in health care

(2013) Jasmin Dischinger et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Activity of Gallidermin on Staphylococcus aureus and Staphylococcus epidermidis Biofilms

(2012) Jongkon Saising et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Manipulation of innate immunity by a bacterial secreted peptide: Lantibiotic nisin Z is selectively immunomodulatory

(2012) Jason Kindrachuk et al.   Innate Immunity

In vitroactivities of antimicrobial cationic peptides; melittin and nisin, alone or in combination with antibiotics against Gram-positive bacteria

(2012) Sibel Dosler et al.   JOURNAL OF CHEMOTHERAPY

Preserving the Lifesaving Power of Antimicrobial Agents

(2011) James M. Hughes   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids

(2011) Christoph M. Ernst et al.   MOLECULAR MICROBIOLOGY

Plantaricin A synthesized by Lactobacillus plantarum induces in vitro proliferation and migration of human keratinocytes and increases the expression of TGF-β1, FGF7, VEGF-A and IL-8 genes

(2011) Daniela Pinto et al.   PEPTIDES

Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes

(2010) Aranya Manosroi et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Pharmacokinetics and Pharmacodynamics of Antibacterial Agents

(2009) Matthew E. Levison et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Lantibiotics: Diverse activities and unique modes of action

(2009) Sikder M. Asaduzzaman et al.   JOURNAL OF BIOSCIENCE AND BIOENGINEERING

Staphylococcus epidermidis — the 'accidental' pathogen

(2009) Michael Otto   NATURE REVIEWS MICROBIOLOGY

The Bacterial Defensin Resistance Protein MprF Consists of Separable Domains for Lipid Lysinylation and Antimicrobial Peptide Repulsion

(2009) Christoph M. Ernst et al.   PLoS Pathogens